Institute of Endocrinology and Nutrition, Medicine School, Unit of Investigation, Surgical Department and Endocrinology Department, Hospital Rio Hortega, University of Valladolid, Valladolid, Spain.
Ann Nutr Metab. 2012;61(1):70-3. doi: 10.1159/000339378. Epub 2012 Jul 26.
Previous studies addressing the changes of glucagon-like peptide-1 (GLP-1) concentrations in morbidly obese patients after bariatric surgery have demonstrated conflicting results. The aim of the present study was to investigate the changes in serum GLP-1 levels 9 months after biliopancreatic diversion in morbidly obese patients without diabetes mellitus.
A sample of 40 morbidly obese patients without diabetes mellitus was enrolled. Biochemical and anthropometrical evaluations were conducted at basal and 9 months after surgery.
The mean patient age was 46.6 ± 13.1 years, and the mean preoperative body mass index (BMI) was 47.1 ± 18.1. A significant decrease in BMI, weight, waist circumference, fat mass, glucose, LDL cholesterol, total cholesterol, and triglyceride levels was observed after 9 months. Serum basal GLP-1 levels did not change after surgery (0.65 ± 0.18 ng/ml vs. 0.66 ± 0.17 ng/ml; n.s.). Postsurgical correlation analysis showed a negative association between basal GLP-1 and HDL cholesterol (r = -0.57; p < 0.01).
Fasting GLP-1 concentrations did not change after massive weight loss with biliopancreatic diversion in morbidly obese patients without diabetes mellitus.
先前研究肥胖症患者接受减重手术后胰高血糖素样肽-1(GLP-1)浓度的变化,结果存在争议。本研究旨在探讨无糖尿病的病态肥胖患者行胆胰分流术后 9 个月血清 GLP-1 水平的变化。
选择 40 例无糖尿病的病态肥胖患者。手术前后进行生化和人体测量学评估。
患者平均年龄为 46.6 ± 13.1 岁,术前平均体重指数(BMI)为 47.1 ± 18.1。9 个月后 BMI、体重、腰围、体脂、血糖、LDL 胆固醇、总胆固醇和甘油三酯水平显著下降。术后基础 GLP-1 水平无变化(0.65 ± 0.18 ng/ml 比 0.66 ± 0.17 ng/ml;n.s.)。术后相关分析显示基础 GLP-1 与高密度脂蛋白胆固醇呈负相关(r = -0.57;p < 0.01)。
无糖尿病的病态肥胖患者行胆胰分流术后,在体重显著减轻的情况下,空腹 GLP-1 浓度未发生变化。